[Results of prophylaxis of Rh-conditioned morbus hemolyticus neonatorum with immunoglobulin-Anti-D(Ig-Anti-D) in a district women's clinic].
D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use; D007231:Infant, Newborn; D008297:Male; D008427:Maternal Health Services; D011247:Pregnancy; D011295:Prenatal Care; D012204:Rh-Hr Blood-Group System; D005719:gamma-Globulins / Q000627:therapeutic use*
D007136:Immunoglobulins; D012204:Rh-Hr Blood-Group System; D005719:gamma-Globulins
Ergebnis der Prophylaxe des Rh-bedingten Morbus haemolyticus neonatorum mit Immunglobulin-Anti-D(IgG-Anti-D) in einer Kreisfrauenklinik.